An anonymous director reports

CRESCO LABS ANNOUNCES UPDATED FIRST QUARTER 2025 EARNINGS DATE

Cresco Labs Inc. will file its first quarter interim financial statements and MD&A (management discussion and analysis) on Friday, May 30, 2025.

Over the past three weeks, the company has worked closely with its independent auditor to complete its review of the financial statements. The company is pleased to report that the review was completed with no material changes from what was prepared for presentation on May 9, 2025, and looks forward to hosting a conference call and webcast to discuss its financial results.

Event:   Cresco Labs first quarter 2025 earnings conference call

Date:  Monday, June 2, 2025

Time:  8:30 a.m. ET

Dial-in numbers:  1-833-470-1428 (United States toll-free) and 1-404-975-4839 (United States local)

Access code:  671160

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs' mission is to normalize and professionalize the medical marijuana industry through a CPG (consumer packaged goods) approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the company is leveraging its scale and agility to grow its portfolio of brands, which include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi, on a national level. The company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering continuing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED (social equity and equality development) initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, work force development and legislative initiatives designed to create the most responsible, respectable and robust medical marijuana industry possible.